Kees-Jan Pronk
WCMM Clinical Researcher | Hematopoietic & Immune Development Our research Hematopoietic cell transplantation (HCT) is often considered a last treatment resort for a number of serious diseases, including malignancies. Prior to HCT, high doses of chemotherapy are administered to the patients in means to eliminate the underlying malignancy such as leukemia. Also, it aims to create space for donor he
https://www.wcmm.lu.se/kees-jan-pronk - 2026-07-17
